An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been identified as the causative agent of coronavirus disease 2019 and is capable of human-to-human transmission and rapid global spread. The rapid emergence and global spread of SARS-CoV-2 has encouraged the establishment of a rapid,...
Main Authors: | Alberto A. Amarilla, Naphak Modhiran, Yin Xiang Setoh, Nias Y. G. Peng, Julian D. J. Sng, Benjamin Liang, Christopher L. D. McMillan, Morgan E. Freney, Stacey T. M. Cheung, Keith J. Chappell, Alexander A. Khromykh, Paul R. Young, Daniel Watterson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2021.625136/full |
Similar Items
-
Rapid Response Subunit Vaccine Design in the Absence of Structural Information
by: Danushka K. Wijesundara, et al.
Published: (2020-11-01) -
Fighting Ebola: A Window for Vaccine Re-evaluation?
by: Keith J Chappell, et al.
Published: (2017-01-01) -
Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
by: Ariel Isaacs, et al.
Published: (2021-01-01) -
The Next Generation of Influenza Vaccines: Towards a Universal Solution
by: Christopher L.D. McMillan, et al.
Published: (2021-01-01) -
Implications of Dengue Virus Maturation on Vaccine Induced Humoral Immunity in Mice
by: Connor A. P. Scott, et al.
Published: (2021-09-01)